Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

DRPLA aggregation and transglutaminase, revisited

Nature Genetics volume 20, page 231 (1998)Cite this article

Access through your institution
Buy or subscribe

Cells that express proteins with long amino-terminal stretches of glutamines, such as those employed by Igarashi et al.1, should be useful for investigating the question of whether crosslinking by transglutaminase2, might cause precipitation of pathological proteins of this type, and whether the enzyme is responsible for the induction of apoptosis. However, in the absence of proper controls3, the study by Igarashi et al. still leaves the issue unresolved.

The authors' claims are based on the effects of cystamine4 and monodansylcadaverine5 (MDC), two compounds that can be used to probe the reactions of transglutaminases. Cystamine is known to inactivate the enzyme3, probably by forming a mixed disulfide. This raises the question of whether similar interference with other thiol enzymes in COS cells (such as the caspases) might also occur. As primary amines, both cystamine and MDC are good substrates for transglutaminase6, and are useful for blocking the glutamine residues in proteins which would otherwise participate in forming Nε(γ-glutamyl)lysine bridges. However, important hurdles must be overcome before making a reasonable case for suggesting that these substrates might specifically inhibit crosslinking by transglutaminase in a cellular setting. Precautions should be taken to inhibit oxidases3,7 so as to prevent possible conversions of the substrates to aldehydes, which would certainly modify a variety of cell constituents. To prove that the transglutaminase-reactive, primary amino group in MDC was needed for inhibition, a minimal requirement would be to compare the effects of MDC with those of its dimethylated tertiary amine analogue3,7. Of course, direct labelling of the DRPLA protein by MDC should also be provided7,8,9. In addition, it is important to bear in mind that the chemical structure of MDC is quite similar to compounds (W5, W7) that are widely marketed as calmodulin inhibitors, raising the possibility that MDC might interfere with the functions of calmodulin in COS cells. It was rather puzzling to find in the article of Igarashi et al. that MDC prevented nuclear fragmentation, that is, apoptotic cell death (Fig. 8e), but was ineffective in blocking the formation of aggregate bodies supposedly produced by the transglutaminase-catalysed crosslinking of the DRPLA protein (Fig. 8b).

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Igarashi, S. et al. Nature Genet. 18, 111–117 (1998).

    Article  CAS  Google Scholar 

  2. Green, H. Cell 74, 955–956 (1993).

    Article  CAS  Google Scholar 

  3. Lorand, L. & Conrad, S.M. Mol. Cell. Biochem. 58, 9–35 (1984).

    Article  CAS  Google Scholar 

  4. Siefring, G.E. Jr, Apostol, A.B., Velasco, P.T. & Lorand, L. Biochemistry 17, 2598– 2604 (1978).

    Article  CAS  Google Scholar 

  5. Lorand, L. et al. Biochemistry 7, 1214– 1223 (1968).

    Article  CAS  Google Scholar 

  6. Lorand, L. et al. Biochemistry 18, 1756– 1765 (1979).

    Article  CAS  Google Scholar 

  7. Cariello, L., Wilson, J. & Lorand, L. Biochemistry 23, 6843– 6850 (1984).

    Article  CAS  Google Scholar 

  8. Cariello, L. et al. Biochemistry 29, 5103– 5108 (1990).

    Article  CAS  Google Scholar 

  9. Murthy, S.N.P., Wilson, J., Zhang, Y. & Lorand, L. J.Biol. Chem. 269, 22907–22911 (1994).

    CAS  PubMed  Google Scholar 

  10. Perutz, M.F., Johnson, T., Suzuki, M. & Finch, J.T. Proc. Natl Acad. Sci. USA 91, 5355–5358 (1994).

    Article  CAS  Google Scholar 

  11. Stott, K., Blackburn, J.M., Butler, P.J. & Perutz, M.F. Proc. Natl Acad. Sci. USA 92, 6509– 6513 (1995).

    Article  CAS  Google Scholar 

  12. Lorand, L. Proc. Natl Acad. Sci. USA 93, 14310– 14313 (1996).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cell and Molecular Biology, Northwestern University Medical School, Chicago, 60611, Illinois, USA

    Laszlo Lorand

Authors
  1. Laszlo Lorand
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Laszlo Lorand.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lorand, L. DRPLA aggregation and transglutaminase, revisited. Nat Genet 20, 231 (1998). https://doi.org/10.1038/3033

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/3033

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing